136 related articles for article (PubMed ID: 28257834)
81. Parstatin inhibits viability of human retinal pigment epithelium cells: an in vitro cytotoxicity study.
Gartaganis PS; Cotsiki M; Anastassiou ED; Tsopanoglou NE; Melachrinou MD
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):5111-5117. PubMed ID: 32432775
[TBL] [Abstract][Full Text] [Related]
82. Suppression of Anti-Inflammatory Mediators in Metabolic Disease May Be Driven by Overwhelming Pro-Inflammatory Drivers.
Sajid S; Zariwala MG; Mackenzie R; Turner M; Nell T; Bellary S; Renshaw D
Nutrients; 2022 Jun; 14(11):. PubMed ID: 35684160
[TBL] [Abstract][Full Text] [Related]
83. Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells.
Morales SA; Telander DG; Mareninov S; Nagy A; Wadehra M; Braun J; Gordon LK
Exp Eye Res; 2012 Sep; 102():10-6. PubMed ID: 22728127
[TBL] [Abstract][Full Text] [Related]
84. Biological and physical approaches on the role of piplartine (piperlongumine) in cancer.
Henrique T; Zanon CF; Girol AP; Stefanini ACB; Contessoto NSA; da Silveira NJF; Bezerra DP; Silveira ER; Barbosa-Filho JM; Cornélio ML; Oliani SM; Tajara EH
Sci Rep; 2020 Dec; 10(1):22283. PubMed ID: 33335138
[TBL] [Abstract][Full Text] [Related]
85. Annexin A1 N-terminal derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions.
Bizzarro V; Fontanella B; Carratù A; Belvedere R; Marfella R; Parente L; Petrella A
PLoS One; 2012; 7(9):e45639. PubMed ID: 23029153
[TBL] [Abstract][Full Text] [Related]
86. Expression Analysis of the Circular RNA Molecules in the Human Retinal Cells Treated with Homocysteine.
Singh M; George AK; Homme RP; Majumder A; Laha A; Sandhu HS; Tyagi SC
Curr Eye Res; 2019 Mar; 44(3):287-293. PubMed ID: 30369271
[TBL] [Abstract][Full Text] [Related]
87. The Effect of Annexin A1 as a Potential New Therapeutic Target on Neuronal Damage by Activated Microglia.
You JE; Jung SH; Kim PH
Mol Cells; 2021 Apr; 44(4):195-206. PubMed ID: 33935041
[TBL] [Abstract][Full Text] [Related]
88. A Comprehensive Proteomic and Phosphoproteomic Analysis of Retinal Pigment Epithelium Reveals Multiple Pathway Alterations in Response to the Inflammatory Stimuli.
Song J; Han D; Lee H; Kim DJ; Cho JY; Park JH; Seok SH
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344885
[TBL] [Abstract][Full Text] [Related]
89. Licarin A as a Novel Drug for Inflammatory Eye Diseases.
Paiva MRB; Vasconcelos-Santos DV; Coelho MM; Machado RR; Lopes NP; Silva-Cunha A; Fialho SL
J Ocul Pharmacol Ther; 2021 Jun; 37(5):290-300. PubMed ID: 33761287
[No Abstract] [Full Text] [Related]
90. Annexin A1 and resolution of inflammation: tissue repairing properties and signalling signature.
Gobbetti T; Cooray SN
Biol Chem; 2016 Oct; 397(10):981-93. PubMed ID: 27447237
[TBL] [Abstract][Full Text] [Related]
91. Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis.
Bonavita AG
Med Hypotheses; 2020 Dec; 145():110352. PubMed ID: 33129009
[TBL] [Abstract][Full Text] [Related]
92. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics.
Perretti M; Dalli J
Br J Pharmacol; 2009 Oct; 158(4):936-46. PubMed ID: 19845684
[TBL] [Abstract][Full Text] [Related]
93. Identification of an LPS-Induced Chemo-Attractive Peptide from
Longo V; Longo A; Martorana A; Lauria A; Augello G; Azzolina A; Cervello M; Colombo P
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32290587
[TBL] [Abstract][Full Text] [Related]
94. Study on the anti-endotoxin effect of sinomenine using an Agilent genome array.
Hu Y; Li B; Wen L; He K
QJM; 2018 Mar; 111(3):171-178. PubMed ID: 29240916
[TBL] [Abstract][Full Text] [Related]
95. Resveratrol encapsulation in high molecular weight chitosan-based nanogels for applications in ocular treatments: Impact on human ARPE-19 culture cells.
Buosi FS; Alaimo A; Di Santo MC; Elías F; García Liñares G; Acebedo SL; Castañeda Cataña MA; Spagnuolo CC; Lizarraga L; Martínez KD; Pérez OE
Int J Biol Macromol; 2020 Dec; 165(Pt A):804-821. PubMed ID: 33011262
[TBL] [Abstract][Full Text] [Related]
96. Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3.
Vong L; D'Acquisto F; Pederzoli-Ribeil M; Lavagno L; Flower RJ; Witko-Sarsat V; Perretti M
J Biol Chem; 2007 Oct; 282(41):29998-30004. PubMed ID: 17681950
[TBL] [Abstract][Full Text] [Related]
97. Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation.
Perretti M; Dalli J
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():449-469. PubMed ID: 36151051
[TBL] [Abstract][Full Text] [Related]
98. Annexin A1 involved in the regulation of inflammation and cell signaling pathways.
Han PF; Che XD; Li HZ; Gao YY; Wei XC; Li PC
Chin J Traumatol; 2020 Apr; 23(2):96-101. PubMed ID: 32201231
[TBL] [Abstract][Full Text] [Related]
99. Annexin A1 in the nervous and ocular systems.
Wang A; Zhang H; Li X; Zhao Y
Neural Regen Res; 2024 Mar; 19(3):591-597. PubMed ID: 37721289
[TBL] [Abstract][Full Text] [Related]
100. Structural Studies of Expressed tIK, Anti-Inflammatory Peptide.
Kim M; Kim Y
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
